未登录

C

Corinne E. Metzger

Purdue University

H指数:15

被引数:667

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gut-derived uremic toxin indoxyl sulfate and aryl hydrocarbon receptor in renal osteodystrophy

肠道来源的尿毒症毒素吲哚硫酸盐和芳烃受体在肾性骨病中的作用

IF3

2026-09-011

OAAI

Chronic, heavy alcohol consumption detrimentally impacts microarchitectural and mechanical properties of bone in crossed high alcohol preferring (cHAP) mice

长期大量饮酒对交叉高酒精偏好（cHAP）小鼠骨的微观结构和力学性质产生不利影响

IF3.6

2026-08-010

PRE

Four weeks of romosozumab treatment increases trabecular bone volume and differentially improves cortical bone in young and aging mice with chronic kidney disease

Calcified Tissue International

IF3.2

2026-07-210

OA

Prolonged secondary hyperparathyroidism in adenine-induced CKD leads to skeletal changes consistent with skeletal hyporesponsiveness to PTH

腺素诱导的CKD中，持续存在的继发性甲状旁腺功能亢进会导致与骨骼对PTH低反应性一致的骨骼改变。

IF2.6

2025-05-230

OA

Combined Romosozumab and Raloxifene treatment targets impaired bone quality in a male murine model of diabetic kidney disease

联合Romosozumab和Raloxifene治疗靶向糖尿病肾病小鼠模型中的受损骨质量

IF3.6

2025-05-010

PRE

Estrogen deficiency induces changes in bone matrix bound water that do not closely correspond with bone turnover

IF3.6

2024-09-011

PRE

Combining anabolic loading and raloxifene improves bone quantity and some quality measures in a mouse model of osteogenesis imperfecta

IF3.6

2024-07-012

PRE

Two Weeks of Continuous Opioid Treatment in an Adenine-Induced Mouse Model of Chronic Kidney Disease Exacerbates the Bone Inflammatory State and Increases Osteoclasts

CALCIFIED TISSUE INTERNATIONAL

IF3.2

2024-06-100

OAAI

Musculoskeletal Health Worsened from Carnitine Supplementation and Not Impacted by a Novel Individualized Treadmill Training Protocol

肌肉骨骼健康因补充肉碱而恶化，并且不受新型个性化跑步机训练方案的影响

AMERICAN JOURNAL OF NEPHROLOGY

IF3.2

2024-02-200

PRE

Inhibition of RANKL improves the skeletal phenotype of adenine-induced chronic kidney disease in mice

抑制RANKL改善腺嘌呤诱导的慢性肾脏病小鼠的骨骼表型

IF2.4

2024-01-141

OAAI

The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) in a Rat Model of CKD

IF2.4

2023-12-074

OAAI

Changes in Bone Quality after Treatment with Etelcalcetide

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2023-08-148

OA

Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms

IF3.6

2023-08-016

PRE

Assessing cortical bone porosity with MRI in an animal model of chronic kidney disease

IF3.6

2023-08-012

OAAI

Exercise training modifies the bone and endocrine response to graded reductions in energy availability in skeletally mature female rodents

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-06-272

OAAI

Single cell cortical bone transcriptomics define novel osteolineage gene sets altered in chronic kidney disease

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-01-269

OAAI

A novel murine model of combined insulin-dependent diabetes and chronic kidney disease has greater skeletal detriments than either disease individually

IF3.6

2022-12-014

OAAI

Femoral Skeletal Perfusion is Reduced in Male Mice with Type 1 Diabetes

CALCIFIED TISSUE INTERNATIONAL

IF3.2

2022-06-151

PRE

Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease

IF3.6

2022-04-019

PRE

Non-Additive Effects of Combined NOX1/4 Inhibition and Calcimimetic Treatment on a Rat Model of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

NOX1/4抑制剂和拟钙剂联合治疗对慢性肾脏病-矿物质和骨障碍 (ckd-mbd) 大鼠模型的非累加作用

IF2.4

2022-02-111

OAAI